[HTML][HTML] Improving cardiac resynchronisation therapy

G Thomas, J Kim, BB Lerman - Arrhythmia & Electrophysiology …, 2019 - ncbi.nlm.nih.gov
CRT is a cornerstone of therapy for patients with heart failure and reduced ejection fraction.
By restoring left ventricular (LV) electrical and mechanical synchrony, CRT can reduce …

Current device therapies for sudden cardiac death prevention–the icd, subcutaneous icd and wearable icd

D Chieng, V Paul, R Denman - Heart, Lung and Circulation, 2019 - Elsevier
Defibrillator technology for sudden cardiac death (SCD) prevention now includes the
transvenous implantable cardiac defibrillator (ICD), subcutaneous ICD (S-ICD) and …

Guía ESC 2021 sobre estimulación cardiaca y terapia de resincronización

M Glikson, JC Nielsen, MB Kronborg… - Revista Española de …, 2022 - iris.unimore.it
Guía ESC 2021 sobre estimulación cardiaca y terapia de resincronización IRIS IRIS Home
Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English …

Advances in cardiac resynchronisation therapy: review of indications and delivery options

D Keene, ZI Whinnett - Heart, 2021 - heart.bmj.com
The aim of cardiac resynchronisation therapy (CRT) is to improve cardiac function by
delivering more physiological cardiac activation to patients with conduction system disease …

Cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis

D Patel, A Kumar, E Black-Maier… - Circulation …, 2021 - Am Heart Assoc
Background: Cardiac resynchronization therapy (CRT) represents a major medical advance
in patients with heart failure with electrical dyssynchrony to improve symptoms, reduce …

Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response

SC Harb, S Toro, JA Bullen, NA Obuchowski, B Xu… - Open …, 2019 - openheart.bmj.com
Objective Determine the prognostic impact of scar quantification (scar%) by cardiac
magnetic resonance (CMR) in predicting heart failure admission, death and left ventricular …

Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in women: a propensity score-matched analysis

G Maglia, M Giammaria, G Zanotto, A D'Onofrio… - Clinical …, 2022 - jacc.org
Background Causes of sex differences in incidence of sustained ventricular arrhythmias
(SVAs) are poorly understood. Objectives This study aims to investigate sex-specific risk of …

Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15 years?

G Boriani, M Ziacchi, M Nesti, A Battista… - International journal of …, 2018 - Elsevier
Cardiac resynchronization therapy (CRT) was proposed around 20 years ago, and its
clinical use rapidly moved from pioneering experiences to randomized controlled trials …

Multi-modality imaging to guide the implantation of cardiac electronic devices in heart failure: is the sum greater than the individual components?

E Galli, A Baritussio, M Sitges… - European Heart …, 2023 - academic.oup.com
Heart failure is a clinical syndrome with an increasing prevalence and incidence worldwide
that impacts patients' quality of life, morbidity, and mortality. Implantable cardioverter …

Impact of cardiac magnetic resonance to arrhythmic risk stratification in nonischemic cardiomyopathy

A Di Marco, E Claver, I Anguera - Cardiac …, 2023 - cardiacep.theclinics.com
Risk stratification for ventricular arrhythmias (VAs) and sudden cardiac death (SCD) in
nonischemic cardiomyopathy (NICM) is a key unresolved issue. Poor risk stratification is …